bortezomib 3.5 MG Injection
- RxCUI
- 402243
- RxNorm name
- bortezomib 3.5 MG Injection
- Display name
- bortezomib 3.5 MG Injection
- Full name
- bortezomib 3.5 MG Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bortezomib | BORTEZOMIB | Avenacy, LLC | decb5d94-2ea2-48d8-b08b-3196b24c0ed3 | 2026-01-09 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Ningbo Shuangcheng Pharmaceutical Co., Ltd. | b17ca681-59a5-4af7-98a4-953b38379893 | 2025-12-30 | Warnings, Adverse reactions | 402243 |
| BORTEZOMIB | BORTEZOMIB | Eugia US LLC | ed526447-a4fe-403b-8f08-21ce1b2fa8b7 | 2025-12-23 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | BluePoint Laboratories | 10f60367-0476-4acd-861b-90c18d4b8164 | 2025-11-20 | Warnings, Adverse reactions | 402243 |
| BORTEZOMIB | BORTEZOMIB | Apotex Corp | b605b541-4bfd-db3e-9710-11c27f6dee6c | 2025-09-16 | Warnings, Adverse reactions | 402243 |
| VELCADE | BORTEZOMIB | Takeda Pharmaceuticals America, Inc. | 1521d321-e724-4ffc-adad-34bf4f44fac7 | 2025-08-28 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | BluePoint Laboratories | c6b620c6-f3d6-4ff3-b46a-50a66e6d41dd | 2025-07-31 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Meitheal Pharmaceuticals Inc. | 322e315f-dd94-475f-94f4-4d86a7eb5590 | 2025-07-23 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Somerset Therapeutics LLC | dc737d3d-2a4e-448a-ad70-e013065c411c | 2025-05-10 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | NorthStar RxLLC | 3f02670b-5683-780c-9d38-5d8f0ef43a14 | 2025-05-06 | Warnings, Adverse reactions | 402243 |
| BORTEZOMIB | BORTEZOMIB | Sagent Pharmaceuticals | 945fbaf0-7a79-4676-aa90-e9a213c0654f | 2025-05-05 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Fresenius Kabi USA, LLC | 3494c357-a692-4e55-89e1-93532b0baef7 | 2025-03-27 | Warnings, Adverse reactions | 402243 |
| BORTEZOMIB | BORTEZOMIB | Zydus Pharmaceuticals USA Inc. | 0eb8daef-18da-43bb-b7c6-38c4c8b5dd80 | 2024-12-05 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Camber Pharmaceuticals, Inc. | 04aafa6a-a50d-4a47-a831-be8e8bb992ac | 2024-07-22 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Dr.Reddy's Laboratories, Inc. | 664bee24-7af2-2099-ac99-5dd71a1e5a14 | 2024-05-17 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Hospira, Inc. | 41e3de39-8278-4a75-badf-601e4602080d | 2024-04-09 | Warnings, Adverse reactions | 402243 |
| BORTEZOMIB | BORTEZOMIB | Eugia US LLC | 76c7c3a5-fd2f-403f-85fd-65a64538eee7 | 2023-10-20 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Sintetica US LLC | d79a71ec-b46d-4961-ad05-8980915cba94 | 2023-10-09 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | Novadoz Pharmaceuticals LLC | d41340c2-7fe8-42b2-aaa5-c9f9b0e9b50e | 2022-07-20 | Warnings, Adverse reactions | 402243 |
| Bortezomib | BORTEZOMIB | BluePoint Laboratories | 12500f21-8e2f-4bcd-861e-4dfca843da2e | 2022-05-16 | Warnings, Adverse reactions | 402243 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1521d321-e724-4ffc-adad-34bf4f44fac7 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 36 | These highlights do not include all the information needed to use VELCADE safely and effectively. See full prescribing information for VELCADE. VELCADE ® (bortezomib) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20250828 |
| 664bee24-7af2-2099-ac99-5dd71a1e5a14 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 17 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION . BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20240517 |
| 191d231a-1fbd-4a65-9d33-d5dc03bac381 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 8 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20220502 |
| 3494c357-a692-4e55-89e1-93532b0baef7 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 7 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20250327 |
| b605b541-4bfd-db3e-9710-11c27f6dee6c | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 6 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20250916 |
| 322e315f-dd94-475f-94f4-4d86a7eb5590 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 6 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20250723 |
| 10f60367-0476-4acd-861b-90c18d4b8164 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 5 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20251120 |
| b17ca681-59a5-4af7-98a4-953b38379893 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 3 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB FOR INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20251230 |
| 3f02670b-5683-780c-9d38-5d8f0ef43a14 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 3 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION . BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20250506 |
| 0eb8daef-18da-43bb-b7c6-38c4c8b5dd80 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 3 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20241205 |
| 76c7c3a5-fd2f-403f-85fd-65a64538eee7 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 3 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20231020 |
| a73d7ea7-d068-4d25-b368-fc3db1898be2 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 3 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB FOR INJECTION (bortezomib) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20220413 |
| c6b620c6-f3d6-4ff3-b46a-50a66e6d41dd | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 2 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20250731 |
| 41e3de39-8278-4a75-badf-601e4602080d | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 2 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20240409 |
| b4fb961a-3133-4082-924d-fb2390aafa7e | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 2 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20231121 |
| d79a71ec-b46d-4961-ad05-8980915cba94 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 2 | These highlights do not include all the information needed to useBORTEZOMIB FOR INJECTIONsafely and effectively. See full prescribing information forBORTEZOMIB FOR INJECTION. BORTEZOMIBfor injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20231009 |
| 854be921-5fd9-482a-8432-a0c0241625f8 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 2 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20211122 |
| decb5d94-2ea2-48d8-b08b-3196b24c0ed3 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20260109 |
| ed526447-a4fe-403b-8f08-21ce1b2fa8b7 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20251223 |
| dc737d3d-2a4e-448a-ad70-e013065c411c | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20250510 |
| 945fbaf0-7a79-4676-aa90-e9a213c0654f | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20250505 |
| 04aafa6a-a50d-4a47-a831-be8e8bb992ac | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20240722 |
| d41340c2-7fe8-42b2-aaa5-c9f9b0e9b50e | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20220720 |
| 12500f21-8e2f-4bcd-861e-4dfca843da2e | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20220516 |
| aef02171-bf8a-43ad-b40c-7642623f9802 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | 20220509 |
| 582c7c0d-fa25-4586-8157-a1e2653d72d9 | bortezomib 3.5 MG Injection [PSN] · bortezomib 3.5 MG Injection [SCD] | 2 | 1 | BORTEZOMIB for injection, for subcutaneous or intravenous use | 20220505 |